Roger Pharma Morphix-GRF | MOD-GRF 1-29 (CJC-1295 without DAC)
Roger Pharma Morphix-GRF is a premium-quality peptide formulated with MOD-GRF 1-29, commonly known as CJC-1295 without DAC. This peptide has become one of the most researched growth hormone-releasing hormone (GHRH) analogs in laboratory and scientific research because of its ability to stimulate natural pulsatile growth hormone release when studied under controlled research conditions.
Unlike CJC-1295 with DAC, which has an extended half-life due to Drug Affinity Complex (DAC) technology, MOD-GRF 1-29 does not contain DAC, allowing it to produce a shorter and more natural growth hormone pulse. This characteristic has made it a preferred research peptide for scientists studying endocrine function, metabolism, tissue regeneration, muscle physiology, and recovery mechanisms.
Roger Pharma is recognized for manufacturing high-quality research peptides using strict quality control and advanced production methods. Morphix-GRF is designed for research applications where purity, consistency, and reliability are essential.
What is MOD-GRF 1-29 (CJC-1295 Without DAC)?
MOD-GRF 1-29 is a modified version of the naturally occurring Growth Hormone Releasing Hormone (GHRH). Scientists developed several amino acid substitutions to improve peptide stability while maintaining biological activity.
Because it lacks DAC technology, MOD-GRF 1-29 has a relatively short half-life of approximately 30 minutes. This enables researchers to study natural pulsatile growth hormone secretion instead of prolonged hormone elevation.
The peptide is commonly investigated alongside GHRP peptides such as:
- Ipamorelin
- GHRP-2
- GHRP-6
- Hexarelin
Researchers frequently examine these combinations because they may produce synergistic growth hormone release during laboratory investigations.
Potential Research Applications
Current scientific research has explored MOD-GRF 1-29 in various experimental areas, including:
- Growth hormone secretion
- IGF-1 regulation
- Muscle protein synthesis
- Tissue repair mechanisms
- Recovery following exercise models
- Fat metabolism
- Sleep quality research
- Healthy aging studies
- Bone metabolism
- Cellular regeneration
These research areas continue to evolve, and many investigations remain ongoing.
Mechanism of Action
MOD-GRF 1-29 acts by binding to GHRH receptors located in the anterior pituitary gland.
During laboratory studies, receptor activation stimulates the release of endogenous growth hormone in a pulsatile manner. Growth hormone may subsequently increase hepatic production of Insulin-like Growth Factor-1 (IGF-1), which plays an important role in numerous physiological processes.
Unlike direct growth hormone administration, MOD-GRF 1-29 works by encouraging the body’s natural hormonal signaling pathways under research conditions.
Why Researchers Choose CJC-1295 Without DAC
Several characteristics make MOD-GRF 1-29 attractive in scientific investigations:
- Mimics natural GH pulses
- Short duration of action
- Improved physiological hormone pattern
- Reduced prolonged GH exposure
- Frequently paired with GHRP peptides
- Well-documented research background
- Excellent compatibility in peptide protocols
These features make it valuable for studies involving endocrine physiology and hormone regulation.
Roger Pharma Morphix-GRF Features
Roger Pharma Morphix-GRF offers several advantages for research laboratories:
- High purity research peptide
- Premium manufacturing standards
- Consistent batch quality
- Sterile lyophilized powder
- Reliable peptide stability
- Suitable for controlled laboratory research
- Professional packaging
- Research-grade formulation
Every production batch undergoes quality control procedures to ensure consistency for laboratory investigations.
Common Areas of Scientific Interest
Researchers continue to investigate MOD-GRF 1-29 in studies involving:
Muscle Physiology
Scientists evaluate growth hormone signaling pathways involved in muscle protein synthesis and recovery following resistance exercise models.
Fat Metabolism
Experimental models examine the peptide’s influence on lipid metabolism and energy utilization.
Recovery Research
Laboratory investigations explore tissue repair processes and cellular recovery mechanisms.
Healthy Aging
Growth hormone naturally declines with age, making MOD-GRF 1-29 an important peptide in aging-related endocrine research.
Sleep Studies
Growth hormone release is closely associated with deep sleep cycles, leading researchers to investigate possible interactions between GHRH analogs and sleep architecture.
Storage Recommendations
Proper storage is important for maintaining peptide stability.
General laboratory recommendations include:
- Store unopened lyophilized peptide in a refrigerator.
- Protect from direct sunlight.
- Avoid excessive heat.
- Store reconstituted solutions under refrigerated conditions.
- Minimize repeated freeze-thaw cycles.
- Follow laboratory handling protocols.
Product Specifications
Brand: Roger Pharma
Product Name: Morphix-GRF
Peptide: MOD-GRF 1-29
Alternative Name: CJC-1295 Without DAC
Category: Research Peptide
Form: Lyophilized Powder
Quality: Research Grade
Frequently Asked Questions
Is MOD-GRF 1-29 the same as CJC-1295?
MOD-GRF 1-29 is commonly referred to as CJC-1295 without DAC. It differs significantly from CJC-1295 with DAC due to its shorter half-life and natural pulsatile activity.
What makes it different from CJC-1295 with DAC?
The absence of DAC technology results in a much shorter duration of action, allowing researchers to study physiological growth hormone pulses rather than prolonged hormone exposure.
Is it commonly combined with other peptides?
In research settings, MOD-GRF 1-29 is frequently studied alongside peptides such as Ipamorelin or GHRP-2 because of their complementary mechanisms in stimulating growth hormone release.
Is Roger Pharma Morphix-GRF suitable for research?
Roger Pharma manufactures Morphix-GRF specifically as a research-grade peptide with an emphasis on purity, consistency, and laboratory quality standards.
Why Buy Roger Pharma Morphix-GRF?
Researchers choose Roger Pharma because of its reputation for quality manufacturing, reliable peptide production, and strict quality control standards. Morphix-GRF provides a consistent source of MOD-GRF 1-29 for scientific investigations focused on growth hormone physiology, metabolism, tissue regeneration, and endocrine function.
Its short-acting profile closely resembles natural hormone release patterns, making it an excellent choice for controlled laboratory studies where physiological signaling is a key area of interest.




Reviews
Clear filtersThere are no reviews yet.